Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors

Oncology (Switzerland)

Volumn 87, Issue 1, 2014, Pages 58-66

  Yamaguchi, Tatsuro ^a   Iijima, Takeru ^a   Wakaume, Rika ^a   Takahashi, Keiichi ^a   Matsumoto, Hiroshi ^a   Nakano, Daisuke ^a   Nakayama, Yujiro ^a   Mori, Takeo ^a   Horiguchi, Shinichiro ^a   Miyaki, Michiko ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Colorectal carcinogenesis; MicroRNA; miR 126; miR 20b

Indexed keywords

MICRORNA 126; MICRORNA 20B;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURGERY; DOWN REGULATION; FAMILIAL COLON POLYPOSIS; GENE EXPRESSION; HEREDITARY COLORECTAL CANCER; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HYPOTHESIS; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MICROSATELLITE INSTABILITY TUMOR; MICROSATELLITE STABLE TUMOR; PRIORITY JOURNAL; TUMOR GROWTH; ADENOMA; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN TISSUE; PROTEIN EXPRESSION;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; CARCINOGENESIS; CARCINOMA; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENE EXPRESSION; HUMANS; MICRORNAS; MICROSATELLITE INSTABILITY;

EID: 84906896673     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000363303     Document Type: Article

References (32)

1. Ambros V: The functions of animal microRNAs. Nature 2004; 431: 350-355.
2. Garzon R, Calin GA, Croce CM: MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-179.
3. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, et al: MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
4. Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs in understanding cancer. Bioinformation 2008; 2: 330-334.
5. Kwak PB, Iwasaki S, Tomari Y: The microRNA pathway and cancer. Cancer Sci 2010; 101: 2309-2315.
6. Negrini M, Calin GA: Breast cancer metastasis: A microRNA story. Breast Cancer Res 2008; 10: 203.
7. Miko E, Czimmerer Z, Csanky E, Boros G, Buslig J, Dezso B, Scholtz B: Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 2009; 35: 646-664.
8. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM: Aberrant expression of oncogenic and tumorsuppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3:e2557.
9. Li XM, Wang AM, Zhang J, Yi H: Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol 2011; 28: 1054-1057.
10. Liu B, Peng XC, Zheng XL, Wang J, Qin YW: MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009; 66: 169-175.
11. Lei Z, Li B, Yang Z, Fang H, Zhang GM, Feng ZH, Huang B: Regulation of HIF-1a and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 2008; 4:e7629.
12. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A: MiR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 2010; 224: 242-249.
13. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-Tumor development. N Engl J Med 1998; 319: 525-532.
14. Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, Kikuchi R, Iwama T, Ikeuchi T, Tonomura A, Nakamura Y, White R, et al: Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990; 50: 7166-7173.
15. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, et al: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2: 169-174.
16. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, et al: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870-6875.
17. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
18. Kanda Y: Free statistical software: EZR (Easy R) on R commander. http://www.jichi.ac.jp/saitama-sct/ SaitamaHP.files/statmedEN.html (accessed April 1, 2013).
19. Schetter AJ, Harris CC: Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 2011; 38: 734-742.
20. de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID: MicroRNAs in colorectal cancer metastasis. J Pathol 2011; 224: 438-447.
21. Yamaguchi T, Bando H, Mori T, Takahashi K, Matsumoto H, Yasutome M, Weich H, Toi M: Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis. Cancer Sci 2007; 98: 405-410.
22. Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzen F, et al: Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol 2008; 26: 2013-2019.
23. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DYR, Srivastava D: MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008; 15: 272-284.
24. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K: The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008; 47: 939-946.
25. Sessa R, Seano G, di Blasio L, Gagliardi PA, Isella C, Medico E, Cotelli F, Bussolino F, Primo L: The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85'. Biochim Biophys Acta 2012; 1823: 1925-1935.
26. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
27. Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R: Identification of microRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer 2012; 51: 707-716.
28. Meister J, Schmidt MH: MiR-126 and miR-126 : New players in cancer. ScientificWorldJournal 2010; 10: 2090-2100.
29. Silva J, Garcia V, Zaballos A, Provencio M, Lombardia L, Almonacid L, Garcia JM, Dominguez G, Peña C, Diaz R, Herrera M, Varela A, et al: Vesicle related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 2011; 37: 617-623.
30. Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, Worley MJ Jr, Berkowitz RS, et al: Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 2012; 11: 2876-2884.
31. Di Lisio L, Gomez-Lopez G, Sanchez-Beato M, Gomez-Abad C, Rodriguez ME, Villuendas R, Ferreira BI, Carro A, Rico D, Mollejo M, Martinez MA, Menarguez J, et al: Mantle cell lymphoma: Transcriptional regulation by microRNAs. Leukemia 2010; 24: 1335-1342.
32. Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR: MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica 2012; 97: 586-594.